| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $40.5M | -35.2% |
| SG&A Expense | $9.7M | -20.7% |
| Operating Income | -$49.3M | +35.3% |
| Interest Expense | $4.1M | +22.3% |
| Net Income | -$51.6M | +33.4% |
| EPS (Basic) | -$6.00 | -700.0% |
| EPS (Diluted) | -$6.00 | -700.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.2M | -91.8% |
| Current Assets | $11.3M | -85.6% |
| Total Assets | $17.7M | -80.8% |
| Current Liabilities | $15.4M | +1.7% |
| Total Liabilities | $17.6M | -61.8% |
| Stockholders' Equity | $123K | -99.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$49.5M | +24.0% |
| Capital Expenditures | $64K | -97.6% |
| Investing Cash Flow | $5.9M | +299.4% |
| Financing Cash Flow | -$26.1M | -176.6% |
| Free Cash Flow | -$49.5M | +26.9% |